Skip to main content

Peer Review reports

From: Serum CGRP in migraine patients using erenumab as preventive treatment

Original Submission
3 May 2022 Submitted Original manuscript
17 May 2022 Reviewed Reviewer Report - Francesca Pistoia
26 May 2022 Reviewed Reviewer Report
26 Jul 2022 Author responded Author comments - Simone de Vries Lentsch
Resubmission - Version 2
26 Jul 2022 Submitted Manuscript version 2
Publishing
26 Jul 2022 Editorially accepted
12 Sep 2022 Article published 10.1186/s10194-022-01483-z

You can find further information about peer review here.

Back to article page